B. Hull

Learn More
With more than 2 years having elapsed since the last case of paralytic poliomyelitis occurred in the Western Hemisphere, significant progress has been made towards the global eradication of wild polioviruses. Poliomyelitis is disappearing from Europe, North Africa, Southern Africa, the Middle East, China, and the Pacific. Reported poliomyelitis cases(More)
While IMR 90 and AG 1519 fibroblasts of low and high population doubling levels grow to confluency when plated on plastic surfaces, they cease to divide within four days when incorporated into collagen lattices. Growth inhibition in the lattices is not due to exhaustion of the medium or isotope, or to contact inhibition; nor is it due to impermeability of(More)
The preferred settings for lumbar support height and depth of 43 male and 80 female office workers were investigated. All subjects were equipped with identical modern office chairs with foam-padded backrests adjustable in both height and depth. Measurements of lumbar support settings were recorded in the workplace, outside of working hours, on four(More)
Immunisation coverage reporting using data from the Australian Childhood Immunisation Register is likely to underestimate immunisation uptake. Since 1997, several initiatives have been introduced to improve both immunisation uptake and notification of immunisation encounters. These initiatives seemed likely to have changed previous coverage estimates.(More)
From 1997 to 1999, Australia changed from a whole-cell based pertussis vaccination program to an acellular one. This paper tracks the transition from whole-cell to acellular pertussis vaccines by calculating the number of whole cell (DTPw) and acellular (DTPa) pertussis vaccines recorded on the Australian Childhood Immunisation Register (ACIR) each month(More)
Immunisation coverage is calculated from Australian Childhood Immunisation Register (ACIR) data using the 'third dose assumption'. This assumes that if the third in a series of vaccine doses has been recorded on the ACIR, the previous two doses have been received, whether or not they are recorded. The objectives of this study were to validate the 'third(More)
BACKGROUND The availability of new pneumococcal conjugate vaccines covering a broader range of serotypes, has seen many countries introduce these into their national immunisation program. When transitioning from 7-valent to 13-valent pneumococcal conjugate vaccines, Australia is one of a small number of countries that included a supplementary dose of the(More)
  • Peter B Mcintyre, Timothy C Heath, Edward D O 'brien, Brynley P Hull
  • 1998
The methodology for calculating immunisation coverage from information in the Australian Childhood Immunisation Register (ACIR) has recently been described in Communicable Diseases Intelligence, 1 and the third quarterly report of national immunisation coverage appears in this issue (page 122). The purpose of this report is to outline some of the(More)
  • 1